Anticancer Activities of Diphenyl Difluoroketone, a Novel Curcumin Analog, on KB Human Oral Cancer Cells

다국어 초록 (Multilingual Abstract)

Effects of diphenyl difluoroketone (EF-24) and curcumin on cell growth and apoptosis induction in KB human oral cancer cells were examined. EF-24 and curcumin inhibited the growth of KB cells in a dose-dependent manner, and the potency of EF-24 was 30 times greater than that of curcumin.
Treatment with EF-24 or curcumin resulted in nuclear condensation and fragmentation. EF-24 and curcumin promoted the proteolytic cleavage of procaspases-3, -7, and -9. Activities of caspases-3 and -7 were detected in living KB cells treated with EF-24 or curcumin. These results suggest that EF-24 and curcumin inhibit cell proliferation and induce apoptosis in KB human oral cancer cells, and have potential properties for development of anti oral cancer drug.

참고문헌 (Reference)

1 van Poppel G, "Vitamins and cancer" 114 : 195-202, 1997

2 Christou L, "Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone" 67 : 51-53, 2001

3 Todd R, "The molecular biology of oral carcinogenesis : toward a tumor progression model" 55 : 613-623, 1997

4 Tian Z, "The cytotoxicity of naturally occurring styryl lactones" 13 : 181-186, 2006

5 Miquel J, "The curcuma antioxidants : pharmacological effects and prospects for future clinical use. A review" 34 : 37-46, 2002

6 Bachmeier B, "The chemopreventive polyphenol Curcumin prevents hematogenousbreast cancer metastases in immunodeficient mice" 19 : 137-152, 2007

7 Hengartner MO, "The biochemistry of apoptosis" 407 : 770-776, 2000

8 Adams BK, "Synthesis and biological evaluation of novel curcumin analogs asanti-cancer and antiangiogenesis agents" 12 : 3871-3883, 2004

9 Hauser PJ, "Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix" 27 : 737-740, 2007

10 Smets LA, "Programmed cell death(apoptosis)and response to anticancer drugs" 5 : 3-9, 1994

11 Kaufmann SH, "Programmed cell death : Alive and well in the new millennium" 11 : 526-534, 2001

12 Pezutto JM, "Plant-derived anticancer agents" 53 : 121-133, 1997

13 Ammon HP, "Pharmacol Curcuma longa" 57 : 1-7, 1991

14 Tan X, "Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells" 17 : 931-940, 2010

15 Banerjee M, "Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat" 25 : 213-224, 2003

16 Green DR, "Mitochondria and apoptosis" 281 : 1309-1312, 1998

17 Tan ML, "Methanolic extract of Pereskia bleo(Kunth)DC. (Cactaceae)induces apoptosis in breast carcinoma, T47-D cell line" 96 : 287-294, 2005

18 Shankar S, "Involvement of Bcl-2 family members, phosphatidylinositol 30-kinase/AKT and mitochondrial p53 in curcumin(diferulolylmethane)-induced apoptosis in prostate cancer" 30 : 905-918, 2007

19 Paschka AG, "Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate" 130 : 1-7, 1998

20 Kaufmann SH, "Induction of apoptosis by cancer chemotherapy" 256 : 42-49, 2000

21 Park DI, "Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiforum in human lung carcinama cells" 51 : 437-443, 2005

22 이희구, "Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells" PERGAMON-ELSEVIER SCIENCE LTD 48 : 883-890, 201003

23 Hoshino T, "Flow cytometric measurement of NK cell cytotoxicity" 36 : 39-43, 1997

24 Notani PN, "Epidemiology and prevention of head and neck cancer: A Global View. In Contemporary Issues in Oral Cancer" Oxford University Press 1-29, 2000

25 Adams BK, "EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redoxdependent mechanism" 16 : 263-275, 2005

26 Liu X, "DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis" 89 : 175-184, 1997

27 Aggarwal BB, "Curcumin induces the degradation of cyclin E expression throughubiquitin-dependent pathway and up-regulates cyclin-dependent kinaseinhibitors p21 and p27 in multiple human tumor cell lines" 73 : 1024-1032, 2007

28 Wahl H, "Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells" 105 : 104-112, 2007

29 Mukhopadhyay A, "Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines" 20 : 7597-7609, 2001

30 Goel A, "Curcumin as Curecumin : from kitchen to clinic" 75 : 787-809, 2008

31 Cohen GM, "Caspases : The executioners of apoptosis" 326 : 1-16, 1997

32 Datta R, "Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis" 272 : 20317-20320, 1997

33 Anand P, "Bioavailability of curcumin : problems and promises" 4 : 807-818, 2007

34 Kim CS, "BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells" 31 : 1096-1100, 2008

35 Reed JC, "Apoptosis-regulating proteins as targets for drug discovery" 7 : 314-319, 2001

36 Hu W, "Anticancer therapy targeting the apoptotic pathway" 4 : 721-729, 2003

37 Cheng YL, "Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo" 222 : 183-193, 2005

38 Mukherjee AK, "Advances in cancer therapy with plant based natural products" 8 : 1467-1486, 2001

39 Sahu RP, "Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells" 100 : 1425-1433, 2009